1. Ali, Z., & El-Mallakh, R. S. (2021). Lithium nephropathy and renal microcysts. Current Psychiatry, 20(6), 34–38, 50.
2. Ali, Z., Tegin, C., & El-Mallakh, R. S. (2020). Evaluating lurasidone as a treatment option for bipolar disorder. Expert Opinion in Pharmacotherapy, 21(3), 253–260. https://doi.org/10.1080/14656566.2019.1695777
3. Amare, A. T., Schubert, K. O., Hou, L., et al. (2018). Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: A genome-wide association study. JAMA Psychiatry, 75, 65–74.
4. Amare, A. T., Schubert, K. O., Hou, L., et al. (2020). Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Molecular Psychiatry. Online ahead of print.
5. Bahji, A., Hawken, E. R., Sepehry, A. A., et al. (2019). ECT beyond unipolar major depression: Systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatrica Scandinavica, 139, 214–226.